Meeder Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,701
Closed -$97K 2509
2021
Q3
$97K Buy
12,701
+335
+3% +$2.84K 0.01% 904
2021
Q2
$120K Buy
12,366
+5,776
+88% +$46K 0.01% 855
2021
Q1
$55K Buy
+6,590
New +$69.6K ﹤0.01% 1076
2020
Q4
Sell
-8,031
Closed -$90K 2346
2020
Q3
$90K Buy
8,031
+646
+9% +$5.91K 0.01% 814
2020
Q2
$46K Buy
7,385
+6,762
+1,085% +$25.9K ﹤0.01% 944
2020
Q1
$1K Buy
+623
New +$1.79K ﹤0.01% 2262
2019
Q2
Sell
-780
Closed -$4K 2187
2019
Q1
$4K Buy
+780
New +$2.05K ﹤0.01% 1463
2018
Q4
Sell
-4,063
Closed -$17K 1848
2018
Q3
$17K Buy
+4,063
New +$22.5K ﹤0.01% 1068
2018
Q2
Sell
-223
Closed -$1K 1718
2018
Q1
$1K Sell
223
-1,084
-83% -$7.71K ﹤0.01% 1502
2017
Q4
$5K Sell
1,307
-610
-32% -$1.59K ﹤0.01% 1334
2017
Q3
$3K Buy
1,917
+1,049
+121% +$1.93K ﹤0.01% 1406
2017
Q2
$2K Hold
868
﹤0.01% 1450
2017
Q1
$3K Buy
868
+62
+8% +$311 ﹤0.01% 1294
2016
Q4
$4K Buy
+806
New +$4.84K ﹤0.01% 888

Other funds holding SRNE